Journal of the American Society of Nephrology
2006 JASN IMPACT FACTOR 7.371 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


J Am Soc Nephrol 19: 884-890, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007040486

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Lorenzen, J.
Right arrow Articles by Susztak, K.
PubMed
Right arrow Articles by Lorenzen, J.
Right arrow Articles by Susztak, K.

BRIEF COMMUNICATIONS

The Role of Osteopontin in the Development of Albuminuria

Johan Lorenzen*, Rajshree Shah*, Alisha Biser*, Serban A. Staicu*, Thiruvur Niranjan*, Ana Maria Garcia*, Antje Gruenwald*, David B. Thomas{dagger}, Ibrahim F. Shatat{ddagger}, Katarine Supe{ddagger}, Robert P. Woroniecki{ddagger} and Katalin Susztak*

Division of Nephrology, Departments of * Medicine, {dagger} Pathology, and {ddagger} Pediatrics, Albert Einstein College of Medicine, Bronx, New York

Correspondence: Dr. Katalin Susztak, Division of Nephrology, Albert Einstein College of Medicine, Bronx, NY 10461. Phone: 718-430-3498; Fax: 718-430-8963; E-mail: ksusztak{at}aecom.yu.edu

Received for publication April 20, 2007. Accepted for publication February 22, 2008.

Several gene array studies have suggested that osteopontin (Opn) expression strongly correlates with albuminuria and glomerular disease. Urinary Opn concentration and kidney Opn immunoreactivity were found to be increased in patients with steroid-sensitive nephrotic syndrome. In addition, renal Opn mRNA was increased in the Ins2Akita mouse model of type 1 diabetic nephropathy, in the LPS-induced albuminuria model, and in glomeruli of puromycin aminonucleotide–induced nephrotic rats. Opn knockout mice did not develop albuminuria in response to LPS injection, and Opn knockout mice were protected from diabetes-induced albuminuria and mesangial expansion. In the glomerulus, Opn immunostaining was increased specifically in podocytes. Treatment of podocytes with recombinant Opn activated the NF-{kappa}B pathway, increased expression of urokinase plasminogen activator and matrix metalloproteinases 2 and 9, and increased podocyte motility. Taken together, these results indicate that Opn plays an important role in the development of albuminuria, possibly by modulating podocyte signaling and motility.







HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP